Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer | stella

Back to Prostate Carcinoma trials

Recruiting

Plain-English translation of NCT07645391 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Trial locations(1 site)

United States

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan

Key details

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

National Cancer Institute (NCI)

Enrollment target

~200 participants

Started

January 2017

Primary completion

January 2030

Age range

35 Years – 70 Years

Sex

Male only

View full record on ClinicalTrials.gov

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Cancer AnswerLine

University of Michigan Rogel Cancer Center

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.